Samsung Invests in Swedish Fertility App for Galaxy Watches
- App uses body temperature to track fertility and ovulation
- Natural Cycles was first such app to win FDA approval, in 2018
The Natural Cycles app.
This article is for subscribers only.
Samsung Electronics Co. joined the latest funding round for Swedish fertility tracking app Natural Cycles as lead investor, seeking to introduce the female-health technology to its Galaxy series smartwatches.
The Natural Cycles app, which monitors body temperature to gauge fertility, in 2018 became the first contraceptive of its kind to be approved by the US Food and Drug Administration.